At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ICVX Icosavax, Inc.
Halted 12-10 15:30:39 EST
15.31
+0.00
0.00%
High15.31Low15.31Vol0.00
Open15.31D1 Closing15.31Amplitude0.00%
Mkt Cap777.79MTradable Cap455.03MTotal Shares50.80M
T/O142.68MT/O Rate0.00%Tradable Shares29.72M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

No data available

Introduction

Company Name.
Icosavax, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington.
Issue price:
--